AbFero Pharmaceuticals
Joshua Dunaief is a Scientific Advisor at AbFero Pharmaceuticals. Joshua is also a Professor of Ophthalmology, University of Pennsylvania. Dr. Dunaief is an expert in age-related macular degeneration and other retinal degenerative diseases. Dr. Dunaief’s lab focuses on developing new understanding and treatment of AMD. He has published over 65 peer-reviewed articles related to AMD, and has NIH funding to study mechanisms of retinal iron transport and the role of iron toxicity in AMD.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
AbFero Pharmaceuticals
AbFero Pharmaceuticals is a privately held clinical-stage pharmaceutical company dedicated to treating diseases of iron overload. Their therapeutic platform addresses transfusion-related iron overload (TIO) and iron accumulation associated with diseases of aging, such as age-related macular degeneration (AMD), and Parkinson’s disease.